Panel reactive antibody in thalassemic serum inhibits proliferation and differentiation of cord blood CD34+ cells in vitro

Pediatr Hematol Oncol. 2009 Jul-Aug;26(5):338-44. doi: 10.1080/08880010902976098.

Abstract

Thalassemic children are at a high risk of graft rejection in cord blood transplantation. To investigate this possible mechanism, the authors evaluated the effect of panel reactive antibody on the growth of CD34(+) cells in vitro. On semisolid medium, CD34(+) cells derived from cord blood were incubated with thalassemic serum, and colony-forming units were counted after 10 days of culture. After incubation with serum-specific panel reactive antibody, profound decreases were found in the numbers of CFU-GM, CFU-GEMM and BFU-E compared with controls. The results indicated that serum-specific panel reactive antibody might have an apparent inhibition effect on proliferation and differentiation of cord blood CD34(+) cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / blood
  • Antibodies / immunology*
  • Antigens, CD34 / immunology*
  • Apoptosis / immunology
  • Cell Differentiation / immunology
  • Cells, Cultured
  • Child
  • Erythroid Precursor Cells / cytology
  • Erythroid Precursor Cells / immunology*
  • Fetal Blood / cytology
  • Fetal Blood / immunology*
  • Granulocyte-Macrophage Progenitor Cells / cytology
  • Granulocyte-Macrophage Progenitor Cells / immunology*
  • Humans
  • Myeloid Progenitor Cells / cytology
  • Myeloid Progenitor Cells / immunology*
  • beta-Thalassemia / blood
  • beta-Thalassemia / immunology*

Substances

  • Antibodies
  • Antigens, CD34